Cite
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
MLA
Dimopoulos, M. A., et al. “The Role of Novel Agents on the Reversibility of Renal Impairment in Newly Diagnosed Symptomatic Patients with Multiple Myeloma.” Leukemia (08876924), vol. 27, no. 2, Feb. 2013, pp. 423–29. EBSCOhost, https://doi.org/10.1038/leu.2012.182.
APA
Dimopoulos, M. A., Roussou, M., Gkotzamanidou, M., Nikitas, N., Psimenou, E., Mparmparoussi, D., Matsouka, C., Spyropoulou-Vlachou, M., Terpos, E., & Kastritis, E. (2013). The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma. Leukemia (08876924), 27(2), 423–429. https://doi.org/10.1038/leu.2012.182
Chicago
Dimopoulos, M A, M Roussou, M Gkotzamanidou, N Nikitas, E Psimenou, D Mparmparoussi, C Matsouka, M Spyropoulou-Vlachou, E Terpos, and E Kastritis. 2013. “The Role of Novel Agents on the Reversibility of Renal Impairment in Newly Diagnosed Symptomatic Patients with Multiple Myeloma.” Leukemia (08876924) 27 (2): 423–29. doi:10.1038/leu.2012.182.